Overview


According to FutureWise analysis the market for antifungal agents in 2023 is US$ 15.91 billion, and is expected to reach US$ 21.7 billion by 2031 at a CAGR of 4.00%.

Antifungal agents, also known as antifungals, are a diverse group of pharmaceutical compounds designed to combat fungal infections in humans. Fungi comprise yeasts and molds that can cause many diseases, such as superficial skin conditions like athlete's foot, ringworm, and severe systemic infections affecting vital organs. These agents function through various mechanisms, targeting specific aspects of fungal biology. 

Azole antifungals, including fluconazole and itraconazole, disrupt fungal cell membranes by inhibiting the synthesis of ergosterol, a critical component for membrane integrity. Polyene antifungals, exemplified by Amphotericin B, bind to ergosterol, creating pores in the cell membrane, which leads to cell death. Echinocandins, represented by caspofungin and micafungin, interfere with fungal cell wall construction by inhibiting β (1,3)-D-glucan synthesis, rendering the cell vulnerable to osmotic stress and ultimately causing cell death. Allylamines like terbinafine and thiocarbamates disrupt ergosterol biosynthesis by inhibiting squalene epoxidase, impairing membrane formation. Pyrimidine analogs, such as flucytosine, are converted to 5-fluorouracil within the fungal cell, hampering RNA and protein synthesis and culminating in cell demise. Topical antifungal treatments encompass creams, ointments, powders, and sprays that are directly administered to the skin or mucous membranes to address localized infections.

FutureWise Market Research has published a report that provides an insightful analysis of Antifungal Agents Market trends that are affecting the overall market growth. This report will provide a detailed analysis of market share, regional insights, and competitor analysis that includes stature of key manufacturers operational in this industry. By the end of the forecast period FutureWise research analysts' projects that the Antifungal Agents Market will experience a significant growth. According to the analysis done, this report will help understand the information referring to the total valuation held by this industry. Additionally, this report will help in understanding the growth opportunities held by various segments of this market, further assist in making better strategic and expansion decisions by key stakeholders of an organization.

  • Asperqillus
  • Alternaria
  • Abbott Laboratories
  • Pfizer
  • Glaxosmithkline
  • Bayer Healthcare
  • Novartis
  • Sanofi-Aventis
  • MerckCo.
  • Kramer Laboratories
  • Enzon Pharmaceuticals
  • Gilead

(Note: The list of the major players will be updated with the latest market scenario and trends)

On the driver's side, the surge in the incidence of fungal infections stands as a primary driver. This surge is attributed to various factors, including the widespread use of antibiotics, immunosuppressive therapies and the expanding population of immunocompromised individuals, such as those with HIV/AIDS or undergoing organ transplantation. Additionally, global travel and increased healthcare interventions have amplified the risk of exposure to fungal pathogens, necessitating effective antifungal treatments. Advancements in medical procedures represent another crucial driver. Complex interventions like organ transplants, chemotherapy, and surgeries often entail the suppression of the immune system, rendering patients highly vulnerable to opportunistic fungal infections. The emergence of resistant fungal strains, particularly in healthcare settings, is a significant factor for research and development in antifungal therapeutics. Technological advancements in diagnostic techniques have led to earlier and more precise identification of fungal infections. This has facilitated timely treatment and bolstered the recognition of the importance of appropriate antifungal therapy in clinical practice. 

Side effects and toxicity related to antifungal drugs pose a significant concern. Some antifungal medicines, especially when administered in high doses or over prolonged periods, can lead to adverse effects. These may encompass hepatotoxicity, nephrotoxicity, and allergic reactions, necessitating vigilant monitoring and dose adjustments. The cost of specific antifungal agents constitutes another restraint. 

Furthermore, the spectrum of activity of some antifungal agents may be limited to specific types of fungi. This can be a challenge when the causative agent of an infection is unknown or in cases involving mixed conditions with various fungal species.

By Drug Types

  • Echinocandins
  • Azoles
  • Ployenes
  • Allylamines
  • Others

By Therapeutic Indications

  • Aspergillosis
  • Dermatophytosis
  • Candidiasis
  • Others

By Application

  • Powders
  • Ointments
  • Drugs
  • Pastes

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

This market research report also emphasis on factors affecting the growth rate in various regions listed above. A deep-down analysis of the region will also be provided in the final version of this market, which is based on the conclusion of primary interviews and secondary data points gathered during the process.

By region, the market is segmented into North America, Latin America, Europe, Asia-Pacific, and Middle East & Africa. North America registered the highest share in the market in 2022 due to the prevalence of immunocompromised individuals due to factors like aging populations, organ transplantation, and cancer treatment contribute to a robust demand for antifungal agents and are driving the market. Expanded healthcare infrastructure, a surge in healthcare expenditure, and increased research and development are occurring, which is enhancing the treatment modalities and interventions with more innovations in this region, which is driving the market.

  • Tier 1 players- established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants

  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth

  • To provide with an exhaustive analysis on the Antifungal Agents Market By Drug Types, By Therapeutic Indications, By Application and By Region
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To evaluate and forecast micro-markets and the overall market
  • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa
  • To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions

  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1. Years Considered for the Study
         3.2. Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1. Secondary Data
          1.1.1. Key Data from Secondary Sources
         1.2. Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Global Antifungal Agents Market Variables, Trends and Scope
    •   1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Technology Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Antifungal Agents Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   Antifungal Agents Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Technology Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Technology Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   Global Antifungal Agents Market, By Drug Types Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Echinocandins
        2. Azoles
        3. Ployenes
        4. Allylamines
        5. Others

  • 8.   Global Antifungal Agents Market, By Therapeutic Indications Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Aspergillosis
        2. Dermatophytosis
        3. Candidiasis
        4. Others

  • 9.   Global Antifungal Agents Market, By Application Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Powders
        2. Ointments
        3. Drugs
        4. Pastes

  • 10.   North America Antifungal Agents Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2023-2031

  • 11.   Latin America Antifungal Agents Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2023-2031

  • 12.   Europe Antifungal Agents Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2023-2031

  • 13.   Asia Pacific Antifungal Agents Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031

  • 14.   Middle East and Africa Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. GCC
         2.2. Israel
         2.3. South Africa
         2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2023-2031

  • 15.   Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix
  • 16.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
    •   1. Asperqillus
         1.1. Company Overview
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. Alternaria
         2.1. Company Overview
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. Abbott Laboratories
         3.1. Company Overview
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. Pfizer
         4.1. Company Overview
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5. Glaxosmithkline
         5.1. Company Overview
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        6. Bayer Healthcare
         6.1. Company Overview
         6.2. Product Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview
        7. Novartis
         7.1. Company Overview
         7.2. Product Portfolio
         7.3. SWOT Analysis
         7.4. Financial Overview
         7.5. Strategic Overview
        8. Sanofi-Aventis
         8.1. Company Overview
         8.2. Product Portfolio
         8.3. SWOT Analysis
         8.4. Financial Overview
         8.5. Strategic Overview
        9. MerckCo.
         9.1. Company Overview
         9.2. Product Portfolio
         9.3. SWOT Analysis
         9.4. Financial Overview
         9.5. Strategic Overview
        10. Kramer Laboratories
         10.1. Company Overview
         10.2. Product Portfolio
         10.3. SWOT Analysis
         10.4. Financial Overview
         10.5. Strategic Overview
        11. Enzon Pharmaceuticals
         11.1. Company Overview
         11.2. Product Portfolio
         11.3. SWOT Analysis
         11.4. Financial Overview
         11.5. Strategic Overview
        12. Gilead
         12.1. Company Overview
         12.2. Product Portfolio
         12.3. SWOT Analysis
         12.4. Financial Overview
         12.5. Strategic Overview

  • 17.   Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the healthcare regulations initiated by administrations
        5. The overall economic slowdown of the developing and developed nations
  • 18.   FutureWise SME Key Takeaway Points for Client

Related Market

Antifungal Treatment Market

Read More

Antifungal Drugs Market

Read More

Antifungal Topical Drugs Market

Read More
Partner

Our Clients